NIH #5R01CA260060-04
Developing new therapeutic strategies for pediatric tumors that lack clinically actionable mutations
- Amount
- $455K
- Period
- 2021-03-17 → 2026-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Gene expression and cancer classification · Molecular Biology
15 total · 5 active
NIH #5R01CA260060-04
NIH #5R01CA260060-03
NIH #5R01CA260060-02
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
Cancer Research · 2026-04-22
Nature Communications · 2025-02-28 · 4 citations
Cancer Research · 2024-09-05
Cancer Research · 2024-09-05
Preclinical Pediatric Molecular Analysis for Therapy Choice (MATCH)Preprint
bioRxiv (Cold Spring Harbor Laboratory) · 2024-07-23 · 1 citations